Detalles de la búsqueda
1.
Validity of Clinical Severity Scores for Respiratory Syncytial Virus: A Systematic Review.
J Infect Dis
; 229(Supplement_1): S8-S17, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37797314
2.
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
J Infect Dis
; 216(4): 405-414, 2017 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28931244
3.
Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.
BMC Infect Dis
; 17(1): 805, 2017 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29284435
4.
Seasonal influenza vaccination in patients with COPD: a systematic literature review.
BMC Pulm Med
; 17(1): 79, 2017 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28468650
5.
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older.
Drug Saf
; 47(4): 365-375, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483767
6.
Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient-reported outcome system for vaccine safety remote monitoring.
Influenza Other Respir Viruses
; 17(3): e13098, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36991538
7.
Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project.
Influenza Other Respir Viruses
; 17(1): e13087, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36550627
8.
Incidence of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Illness in Infants in Low- and Middle-Income Regions During the Coronavirus Disease 2019 Pandemic.
Open Forum Infect Dis
; 10(12): ofad553, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38088983
9.
Brand-Specific Enhanced Safety Surveillance Study of GSK's Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season.
Infect Dis Ther
; 11(1): 463-483, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34961900
10.
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
Hum Vaccin Immunother
; 18(5): 2058304, 2022 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35486410
11.
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative.
Expert Rev Vaccines
; 21(12): 1701-1710, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36261918
12.
Burden of Seasonal Influenza A and B in Panama from 2011 to 2017: An Observational Retrospective Database Study.
Infect Dis Ther
; 10(4): 2465-2478, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34424506
13.
Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations.
Hum Vaccin Immunother
; 16(4): 836-845, 2020 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31647348
14.
Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.
Drug Saf
; 43(3): 265-279, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31884676
15.
Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season.
Hum Vaccin Immunother
; 16(8): 1762-1771, 2020 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32118513
16.
Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives.
Hum Vaccin Immunother
; 15(11): 2624-2636, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116631
17.
Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis.
Adv Ther
; 36(12): 3340-3355, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31595482
18.
Passive enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season.
BMJ Open
; 9(8): e028043, 2019 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31427321
19.
Enhanced passive surveillance of influenza vaccination in England, 2016-2017- an observational study using an adverse events reporting card.
Hum Vaccin Immunother
; 15(5): 1048-1059, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30648923
20.
Enhanced Safety Surveillance of Influenza Vaccines in General Practice, 2015-16: Feasibility Study.
JMIR Public Health Surveill
; 5(4): e12016, 2019 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31724955